These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 17013730)
1. Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture. Iba K; Takada J; Hatakeyama N; Kaya M; Isogai S; Tsuda H; Obata H; Miyano S; Yamashita T J Orthop Sci; 2006 Oct; 11(5):446-9. PubMed ID: 17013730 [TBL] [Abstract][Full Text] [Related]
2. Improvement in the rate of inadequate pharmaceutical treatment by orthopaedic surgeons for the prevention of a second fracture over the last 10 years. Iba K; Dohke T; Takada J; Sasaki K; Sonoda T; Hanaka M; Miyano S; Yamashita T J Orthop Sci; 2018 Jan; 23(1):127-131. PubMed ID: 28982605 [TBL] [Abstract][Full Text] [Related]
3. Distal radius fracture risk reduction with a comprehensive osteoporosis management program. Harness NG; Funahashi T; Dell R; Adams AL; Burchette R; Chen X; Greene D J Hand Surg Am; 2012 Aug; 37(8):1543-9. PubMed ID: 22748352 [TBL] [Abstract][Full Text] [Related]
4. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients. Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417 [TBL] [Abstract][Full Text] [Related]
5. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture]. Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575 [TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of osteoporosis following fragility fractures of the distal radius in a large health maintenance organization. Benzvi L; Gershon A; Lavi I; Wollstein R Arch Osteoporos; 2016; 11():20. PubMed ID: 27142832 [TBL] [Abstract][Full Text] [Related]
7. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries. Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068 [TBL] [Abstract][Full Text] [Related]
8. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009. Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929 [TBL] [Abstract][Full Text] [Related]
9. Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre. Daruwalla ZJ; Huq SS; Wong KL; Nee PY; Leong KM; Pillay KR; Murphy DP Osteoporos Int; 2016 Jan; 27(1):361-6. PubMed ID: 26510846 [TBL] [Abstract][Full Text] [Related]
10. Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture: Analysis of a Large Population Sample. Bawa HS; Weick J; Dirschl DR J Bone Joint Surg Am; 2015 Oct; 97(19):1555-62. PubMed ID: 26446962 [TBL] [Abstract][Full Text] [Related]
11. Trends in and relation between hip fracture incidence and osteoporosis medication utilization and prices in Estonia in 2004-2015. Laius O; Pisarev H; Maasalu K; Kõks S; Märtson A Arch Osteoporos; 2017 Dec; 12(1):48. PubMed ID: 28497319 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis. Tsukutani Y; Hagino H; Ito Y; Nagashima H Osteoporos Int; 2015 Sep; 26(9):2249-55. PubMed ID: 25986382 [TBL] [Abstract][Full Text] [Related]
13. Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Brozek W; Reichardt B; Zwerina J; Dimai HP; Klaushofer K; Zwettler E Osteoporos Int; 2016 Jan; 27(1):387-96. PubMed ID: 26576544 [TBL] [Abstract][Full Text] [Related]
14. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China. Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451 [TBL] [Abstract][Full Text] [Related]
15. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project. Morell S; Hemmeler C; Amsler F; Gross T Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555 [TBL] [Abstract][Full Text] [Related]
17. Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Maravic M; Le Bihan C; Landais P; Fardellone P Osteoporos Int; 2005 Dec; 16(12):1475-80. PubMed ID: 16217587 [TBL] [Abstract][Full Text] [Related]
18. Fracture prevention service to bridge the osteoporosis care gap. Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707 [TBL] [Abstract][Full Text] [Related]
19. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012. Cheung MY; Ho AW; Wong SH Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735 [TBL] [Abstract][Full Text] [Related]
20. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces. Crilly RG; Kloseck M; Chesworth B; Mequanint S; Sadowski E; Gilliland J Osteoporos Int; 2014 Jan; 25(1):205-10. PubMed ID: 23907572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]